HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$22.81
Day range
$22.06 - $23.39
Year range
$6.42 - $24.05
Market cap
1.21B USD
Avg Volume
468.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.94M | 15.17% |
Net income | -29.87M | -24.37% |
Net profit margin | — | — |
Earnings per share | -0.50 | -21.95% |
EBITDA | -32.81M | -15.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 274.92M | -23.66% |
Total assets | 301.85M | -20.69% |
Total liabilities | 21.34M | 16.60% |
Total equity | 280.51M | — |
Shares outstanding | 53.37M | — |
Price to book | 4.34 | — |
Return on assets | -26.42% | — |
Return on capital | -27.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -29.87M | -24.37% |
Cash from operations | -22.38M | -25.04% |
Cash from investing | -14.81M | -168.68% |
Cash from financing | 647.00K | -12.92% |
Net change in cash | -36.54M | -930.05% |
Free cash flow | -11.24M | -25.44% |
About
Founded
2018
Headquarters
Website
Employees
60
